Literature DB >> 31857695

Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure.

Shinya Kajiwara1, Kenichiro Ishii1,2, Takeshi Sasaki1, Manabu Kato1, Kohei Nishikawa1, Hideki Kanda1, Kiminobu Arima1, Masatoshi Watanabe2, Yoshiki Sugimura3.   

Abstract

The normal prostate epithelial structure is maintained by homeostatic interactions with smooth muscle cells. However, structural alterations of the stroma are commonly observed in prostatic proliferative diseases, leading to the abnormalities of prostate epithelial structure. A decrease in the androgen level experimentally induces stromal remodeling, i.e., replacement of smooth muscle cells with fibroblasts or myofibroblasts. In this study, we investigated the effects of castration-induced stromal remodeling and subsequent aberrant activation of epithelial-stromal interactions on the reconstituted human prostate-like epithelial structure. We performed in vivo experiments using the human prostate epithelial cell line BPH-1 and fetal rat urogenital sinus mesenchyme to generate heterotypic tissue recombinants that form human prostate-like epithelial structure (i.e., solid- and canalized-epithelial cords). Host mice were castrated at 12 weeks post transplantation (castration) and implanted with a dihydrotestosterone pellet at 14 days post castration (androgen replacement treatment; ART). In the castration group, the percentages of fibrotic area and disrupted prostate epithelial structure without the basement membrane (BM) increased proportionally in a time-dependent manner, but were suppressed by ART. In the castration group, tenascin-C (TNC)-positive fibroblasts were abundant in the stroma surrounding disrupted prostate epithelial structure without the BM. TGF-β1 secretion from BPH-1 cells was increased by co-culturing with human primary cultured prostate fibroblasts. TNC mRNA expression was increased in fibroblasts co-culturing with BPH-1 cells and was suppressed by treatment with a TGF-β RI kinase inhibitor. Moreover, in the castration group, the percentage of p-Smad2-positive cells was significantly higher in the stroma surrounding disrupted prostate epithelial structure without the BM. Our results demonstrate that castration-induced stromal remodeling disrupted the reconstituted human prostate-like epithelial structure and induced the appearance of TNC-positive fibroblasts accompanied by activation of TGF-β signaling. The alteration of prostate stromal structure may be responsible for loss of the BM and epithelial cell polarity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31857695     DOI: 10.1038/s41374-019-0352-4

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  41 in total

1.  Effect of androgen ablation on prostatic cell differentiation in dogs.

Authors:  Falah Shidaifat; M Daradka; R Al-Omari
Journal:  Endocr Res       Date:  2004-08       Impact factor: 1.720

Review 2.  Growth factor involvement in progression of prostate cancer.

Authors:  P J Russell; S Bennett; P Stricker
Journal:  Clin Chem       Date:  1998-04       Impact factor: 8.327

3.  Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition.

Authors:  Y Shibata; K Ito; K Suzuki; K Nakano; Y Fukabori; R Suzuki; Y Kawabe; S Honma; H Yamanaka
Journal:  Prostate       Date:  2000-01       Impact factor: 4.104

Review 4.  Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Authors:  Leland W K Chung; Adam Baseman; Vasily Assikis; Haiyen E Zhau
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

5.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

Authors:  Jennifer A Tuxhorn; Gustavo E Ayala; Megan J Smith; Vincent C Smith; Truong D Dang; David R Rowley
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

6.  Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement.

Authors:  H F English; R J Santen; J T Isaacs
Journal:  Prostate       Date:  1987       Impact factor: 4.104

7.  Structural changes in alpha1-adrenoceptor antagonist-treated human prostatic stroma.

Authors:  Tetsuya Imamura; Kenichiro Ishii; Hideki Kanda; Shigeki Arase; Yuko Yoshio; Yasuhide Hori; Norihito Soga; Hideaki Kise; Kiminobu Arima; Yoshiki Sugimura
Journal:  Clin Exp Med       Date:  2009-10-14       Impact factor: 3.984

8.  Effects of long-term castration on the smooth muscle cell phenotype of the rat ventral prostate.

Authors:  Eliane Antonioli; Alexandre Bruni Cardoso; Hernandes F Carvalho
Journal:  J Androl       Date:  2007-05-23

9.  Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

Authors:  Damien A Leach; Eleanor F Need; Roxanne Toivanen; Andrew P Trotta; Helen M Palethorpe; Helen M Palenthorpe; David J Tamblyn; Tina Kopsaftis; Georgina M England; Eric Smith; Paul A Drew; Carole B Pinnock; Peng Lee; Jeff Holst; Gail P Risbridger; Samarth Chopra; Donald B DeFranco; Renea A Taylor; Grant Buchanan
Journal:  Oncotarget       Date:  2015-06-30

10.  Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin.

Authors:  Begum Erdogan; Mingfang Ao; Lauren M White; Anna L Means; Bryson M Brewer; Lijie Yang; M Kay Washington; Chanjuan Shi; Omar E Franco; Alissa M Weaver; Simon W Hayward; Deyu Li; Donna J Webb
Journal:  J Cell Biol       Date:  2017-10-11       Impact factor: 10.539

View more
  3 in total

1.  The Prostate-Associated Gene 4 (PAGE4) Could Play a Role in the Development of Benign Prostatic Hyperplasia under Oxidative Stress.

Authors:  Yan Li; Jianmin Liu; Daoquan Liu; Zhen Wang; Yongying Zhou; Shu Yang; Feng Guo; Liang Yang; Xinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-05-19       Impact factor: 7.310

2.  The IL-4/IL-13 signaling axis promotes prostatic fibrosis.

Authors:  Quentin D'Arcy; Mehrnaz Gharaee-Kermani; Alisa Zhilin-Roth; Jill A Macoska
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

Review 3.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.